Since the last time I covered Philip Morris International (NYSE: PM ), its stock price has increased by 9.9%, constituting a total return of 11.2%. I indicated then that I didn't have a position in PM butWelcome to Cash Flow Venue, where dividends do the heavy lifting! Blending my financial chops with the timeless wisdom of value investing (and love for steady income), I’ve built a rock-solid pillar in my financial foundation through dividend investing. I believe it’s one of the most accessible paths to ach ...

Group 1 - Philip Morris (PM) is a notable stock in the Consumer Staples sector, which consists of 184 individual stocks and holds a Zacks Sector Rank of 9 [1] - PM has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, with the consensus estimate for its full-year earnings increasing by 2% over the past quarter [2] - Year-to-date, PM has returned approximately 28.5%, significantly outperforming the Consumer Staples sector average return of 10.4% [2] Group 2 - Another strong performer in the Consumer Staples sector is Pilgrim's Pride (PPC), which has achieved a year-to-date return of 55.8% [2] - The consensus estimate for Pilgrim's Pride's current year EPS has risen by 12.7% in the last three months, and it holds a Zacks Rank of 1 (Strong Buy) [3] - Philip Morris is part of the Tobacco industry, which includes 6 stocks and currently ranks 15 in the Zacks Industry Rank, with an average gain of 30.5% year-to-date, indicating PM is slightly underperforming its industry [3]

Tobacco giant Philip Morris International Inc. PM invested $232 million to expand its Kentucky facility. Goldman Sachs analyst Bonnie Herzog expects the Marlboro parent company to report strong results for its fiscal third quarter on Oct. 22.Herzog reiterated a Buy rating and raised the price target from $126 to $140.The Philip Morris International Thesis: The cigarette producer is likely to "comfortably reach" a 10% share of the U.S. combustible and heat-not-burn market by around 2030, Herzog wrote in a no ...

The interest of US tobacco investors is focused mainly on two companies: Altria ( MO ) and British American Tobacco ( BTI ). These two have the lion's share of sales inTed Waller is a private investor who bought his first stock at age 13 (GTE) and has over 55 years of investing experience. His focus is on value and favorable risk/reward ratio, and special situations. Acquiring wealth is an incremental process that requires setting goals, adherence to principles, and patience.Analyst’s Disclosure: I/we have ...

In a major move, Vectura Fertin Pharma, Inc., an affiliate of Philip Morris International Inc. (PM) , announced the sale of Vectura Group Ltd. to Molex Asia Holdings Ltd. This decision comes amid ongoing criticism of PM’s ownership of the asthma inhaler manufacturer as PM attempts to transition from tobacco to a broader healthcare and wellness group. Philip Morris stated that this transaction allows Vectura to operate under Phillips Medisize, a Molex subsidiary, which is better positioned to advance its inh ...

Core Viewpoint - Philip Morris International Inc. (PM) is experiencing strong upward momentum in its stock performance, driven by effective pricing strategies and a successful transition to smoke-free products, positioning the company favorably in the evolving tobacco industry [1][4][8]. Stock Performance - As of September 18, PM was trading at $120.96, above its 200-day simple moving average (SMA) of $99.21 and 50-day SMA of $117.16, indicating a sustained uptrend [1]. - PM shares have increased by 19.5% over the past three months, outperforming the industry growth of 18.9%, the Consumer Staples sector's increase of 8.4%, and the S&P 500 Index's rise of 2.6% [2]. Pricing Strategy - The company has maintained profitability despite declining cigarette shipment volumes through an effective pricing strategy, anticipating a 7-8% rise in combustible product pricing in 2024 [4]. Smoke-Free Transition - Smoke-free products accounted for 38.1% of PM's net revenues in Q2 2024, with a goal to derive over two-thirds of total revenues from these products by 2030 [5]. - Revenues from the smoke-free business rose 13.6% in Q2 2024, with organic growth at 18.3%, driven by strong performance in IQOS and increased shipments of ZYN [6]. Future Expectations - PM raised its full-year guidance for 2024, expecting net revenues to increase by 7.5-9% on an organic basis, with operating income projected to rise by 11-13% [7]. - Adjusted EPS for 2024 is anticipated to be in the range of $6.33-$6.45, reflecting a growth of 5.3-7.3% [7]. Investment Outlook - The company is positioned as a compelling investment opportunity due to its robust momentum, commitment to innovative smoke-free solutions, and proven profitability [8].

Investors have mostly given up on this sector, but returns have been massive over the long run.It can pay to track the investing legends. Billionaire Stanley Druckenmiller put up 30% returns for 30 years when running his hedge fund, and he never had a down year for his investors. Clearly, he is one of the best investors out there, making it worthwhile to track what he is buying and selling.While you shouldn't blindly follow the investing legends, it can be a great source of inspiration for potential new sto ...

In a major move, Vectura Fertin Pharma, Inc., an affiliate of Philip Morris International Inc. (PM) , announced the sale of Vectura Group Ltd. to Molex Asia Holdings Ltd. This decision comes amid ongoing criticism of PM’s ownership of the asthma inhaler manufacturer as PM attempts to transition from tobacco to a broader healthcare and wellness group.Philip Morris stated that this transaction allows Vectura to operate under Phillips Medisize, a Molex subsidiary, which is better positioned to advance its inha ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.It also includes access to the Zacks Style Scores.What are the Zacks Style Scores?The Zacks ...

FotografiaBasica Philip Morris (NYSE:PM) is one of the largest tobacco companies in the world, with a market capitalization of almost $200 billion. The company has a dividend of more than 4% and an incredibly strong portfolio of assets. As we'll see throughout this article, Philip Morris has an impressive portfolio of assets that will support future shareholder returns. We last discussed the company just over a year ago. Since then, the company has almost doubled the performance of the S&P 500, supporte ...